Agenus Inc.

11/08/2024 | Press release | Distributed by Public on 11/08/2024 15:06

Amendment to Current Report Form 8 K/A

8-K/A

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K/A

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 08, 2024

AGENUS INC.

(Exact name of Registrant as Specified in Its Charter)

Delaware

000-29089

06-1562417

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

3 Forbes Road

Lexington, Massachusetts

02421

(Address of Principal Executive Offices)

(Zip Code)

Registrant's Telephone Number, Including Area Code: 781 674-4400

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

Trading
Symbol(s)


Name of each exchange on which registered

Common Stock, $0.01 par value per share

AGEN

The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Explanatory Note

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 8, 2024, Agenus Inc. (the "Company") filed a Current Report on Form 8-K (the "Original Report") to disclose the appointment of Thomas L. Harrison to the Company's Board of Directors (the "Board"). At the time of filing, the Board had not determined Mr. Harrison's Board committee assignments.

Pursuant to Instruction 2 of Item 5.02 of Form 8-K, the Company is filing this amendment to the Original Report for the sole purpose of disclosing that, effective on November 5, 2024 at 5:00 pm Eastern Time, the Board appointed Mr. Harrison to serve on the Board's Audit and Finance Committee, for which he has been appointed chair, and the Board's Corporate Governance and Nominating Committee.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:

November 8, 2024

By:

/s/ Christine M. Klaskin

Christine M. Klaskin, VP Finance